MARATTO

article · Pathology - Research and Practice

Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression

202322 citationsBadr University in Cairo

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Flavonoids in Medical Research
  • PI3K/AKT/mTOR signaling in cancer
  • Cell death mechanisms and regulation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.prp.2023.154807

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.